Cargando…

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?

BACKGROUND: Chronic obstructive pulmonary disease (COPD) manifests itself in complex ways, with local and systemic effects; because of this, a multifactorial approach is needed for disease evaluation, in order to understand its severity and impact on each individual. Thus, our objective was to study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carvalho-Jr, Luiz Carlos S, Trimer, Renata, Arêas, Guilherme PT, Caruso, Flávia CR, Zangrando, Katiany TL, Jürgensen, Soraia Pilon, Bonjorno, José C, de Oliveira, Cláudio Ricardo, Cabiddu, Ramona, Mendes, Renata G, Borghi-Silva, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183695/ https://www.ncbi.nlm.nih.gov/pubmed/30349223 http://dx.doi.org/10.2147/COPD.S167369

Ejemplares similares

Chronic obstructive pulmonary disease severity and its association with obstructive sleep apnea syndrome: impact on cardiac autonomic modulation and functional capacity
por: Zangrando, Katiany Thays Lopes, et al.
Publicado: (2018)

Is cardiac autonomic modulation during upper limb isometric contraction and Valsalva maneuver impaired in COPD patients?
por: Goulart, Cássia da Luz, et al.
Publicado: (2017)

Respiratory muscle strength effect on linear and nonlinear heart rate variability parameters in COPD patients
por: Goulart, Cássia Da Luz, et al.
Publicado: (2016)

Prediction of Cardiorespiratory Fitness by the Six-Minute Step Test and Its Association with Muscle Strength and Power in Sedentary Obese and Lean Young Women: A Cross-Sectional Study
por: Carvalho, Lívia Pinheiro, et al.
Publicado: (2015)

Inductive plethysmography potential as a surrogate for ventilatory measurements during rest and moderate physical exercise
por: Cabiddu, Ramona, et al.
Publicado: (2016)

Are Complexity Metrics Reliable in Assessing HRV Control in Obese Patients During Sleep?
por: Cabiddu, Ramona, et al.
Publicado: (2015)

Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients — a Randomized Controlled Trial
por: Bassi, Daniela, et al.
Publicado: (2016)

Effects of Coexistence Hypertension and Type II Diabetes on Heart Rate Variability and Cardiorespiratory Fitness
por: Bassi, Daniela, et al.
Publicado: (2018)

Increased parasympathetic cardiac modulation in patients with acute exacerbation of COPD: how should we interpret it?
por: Kabbach, Erika Zavaglia, et al.
Publicado: (2017)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Functional and systemic effects of whole body electrical stimulation post bariatric surgery: study protocol for a randomized controlled trial
por: Delgado André, Larissa, et al.
Publicado: (2018)

The Value of Cardiopulmonary Exercise Testing in Determining Severity in Patients with both Systolic Heart Failure and COPD
por: Goulart, Cássia da Luz, et al.
Publicado: (2020)

Pulmonary function and functional capacity cut-off point to establish sarcopenia and dynapenia in patients with COPD
por: Mansour, Kamila Mohammad Kamal, et al.
Publicado: (2019)

Publisher Correction: The Value of Cardiopulmonary Exercise Testing in Determining Severity in Patients with both Systolic Heart Failure and COPD
por: da Luz Goulart, Cássia, et al.
Publicado: (2020)

Responses to incremental exercise and the impact of the coexistence of HF and COPD on exercise capacity: a follow-up study
por: Dos Santos, Polliana B., et al.
Publicado: (2022)

Does peripheral arterial occlusive disease influence muscle strength and exercise capacity in COPD patients?
por: Miranda, Natacha Angélica da Fonseca, et al.
Publicado: (2017)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Does the incremental shuttle walk test require maximal effort in young obese women?
por: Jürgensen, S.P., et al.
Publicado: (2016)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Exploring Vascular Function Biomarkers: Implications for Rehabilitation
por: Phillips, Shane A., et al.
Publicado: (2017)

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

Glycemic control affecting the autonomic modulation in type 2 diabetes
por: Bassi, Daniela, et al.
Publicado: (2015)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Estimation of TGF-β1 genotypes in Egyptian smokers; association with FEV(1) in COPD patients
por: Bohy, Mohammad El, et al.
Publicado: (2010)

A novel CT-emphysema index/FEV(1) approach of phenotyping COPD to predict mortality
por: Loh, Li-Cher, et al.
Publicado: (2018)

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
por: Kirkby, Jane, et al.
Publicado: (2019)

Can Non-invasive Ventilation Modulate Cerebral, Respiratory, and Peripheral Muscle Oxygenation During High-Intensity Exercise in Patients With COPD-HF?
por: Goulart, Cássia da Luz, et al.
Publicado: (2022)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Annual FEV(1) changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study
por: Takahashi, Toru, et al.
Publicado: (2014)

FEV(1) inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure
por: Montaño, Martha, et al.
Publicado: (2014)

Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV(1) in COPD patients
por: Huang, Cuiping, et al.
Publicado: (2013)

Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study
por: Zendedel, Abolfazl, et al.
Publicado: (2015)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uqgltptdb1o54m8vq693fkk013